Observational Study of the Interaction Between Hepatitis C Virus Infection and Pregnancy
NCT ID: NCT05929963
Last Updated: 2023-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2023-05-09
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Effect of hepatitis C virus on liver function in pregnant women Mother-to-child transmission rate in pregnant women with hepatitis C
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility and Acceptability of HCV Treatment in Pregnancy
NCT06367465
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
NCT05368974
Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C
NCT04071353
An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis C
NCT04301882
Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
NCT07040319
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HCV Ab(+）HCVRNA（-）
HCV Ab（+） HCVRNA(-) in pregnant women
HCV infection status
Divided into 3 groups based on HCVAb and HCVRNA status
HCV Ab(+）HCVRNA（+）
HCV Ab(+）HCVRNA（+）in pregnant women
HCV infection status
Divided into 3 groups based on HCVAb and HCVRNA status
HCVAb(-) HCVRNA(-)
HCV Ab(-）HCVRNA（-）in pregnant women
HCV infection status
Divided into 3 groups based on HCVAb and HCVRNA status
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HCV infection status
Divided into 3 groups based on HCVAb and HCVRNA status
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pregnant women aged 20-45 years
* complete pregnancy data available
Exclusion Criteria
* Combination of other viral infections with potential loss of liver function
* Mental illness
* Patients with immunosuppression
* Mother with cirrhosis or liver tumour
20 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Ditan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yao Xie
Head of Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yao Xie, Doctor
Role: PRINCIPAL_INVESTIGATOR
Beijing Ditan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Ditan Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DTXY28
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.